Clinical Study

Stem Cell Transplant In Mcl With Mutated Tp53

Posted Date: May 6, 2022

  • Investigator: Bryan Hambley
  • Type of Study: Observational/Survey

This retrospective study will evaluate outcomes in patients with mantle cell lymphoma with dysfunctional TP53, particularly evaluating if stem cell transplant helps mitigate the negative prognostic outcomes with these patients.




Mantle, Transplant, Tp53

For More Information:

Bryan Hambley

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.